Insurance Coverage for Endoscopic Bariatric Therapies in 2026: Analyses of Top Insurers in the US and Internal Validation

By afschroeder • May 30, 2026

Garcia-Corella J, Shah S, Okafor C, Bechenati D, Arif Y, Bahdi F, Villarruel E, Larios K, Alhanaee M, Thaker A, Rosenthal RJ, Muthusamy VR, Issa D. Insurance Coverage for Endoscopic Bariatric Therapies in 2026: Analyses of Top Insurers in the US and Internal Validation. J Surg Res. 2026 May 28;324:155-161. doi: 10.1016/j.jss.2026.04.039. Epub ahead of print. PMID: 42208214.

Tags: DGSOM Student, Digestive Diseases, endobariatrics, Endoscopic bariatric therapies, Fellow, General Internal Medicine, Insurance, Kern, Obesity, Publications, Resident

Characterizing Abdominal Pain and Irritable Bowel Syndrome Among Individuals With Cirrhosis: Results of a Nationwide Survey

Deng LX, Almario CV, Lai JC, Spiegel BMR, Rubin JB. Characterizing Abdominal Pain and Irritable Bowel Syndrome Among Individuals With Cirrhosis: Results of a Nationwide[...]

Fraudulent and Imposter Participants in Qualitative Research: Experiences from Two Multi-Site Studies

Harden D, Rodriguez N, Roybal K, Coffin T, Johnson G, Le Beaux K, Connolly M, Rountree J, Ukaegbu C, Revette AC, Nava-Coulter B, Caruso A,[...]

Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): consensus on obesity and cardiometabolic comorbidities in inflammatory bowel disease using systematic reviews and the RAND/UCLA appropriateness method

Devi J, Samaan S, Sehgal P, Mohamed M, Vincent M, Coombs S, Doering M, Barnes EL, Johnson AM, Yarur AJ, Deepak P. Modulate Obesity and[...]